438 related articles for article (PubMed ID: 28335462)
1. Therapeutic Potentials of Microalgae in the Treatment of Alzheimer's Disease.
Olasehinde TA; Olaniran AO; Okoh AI
Molecules; 2017 Mar; 22(3):. PubMed ID: 28335462
[TBL] [Abstract][Full Text] [Related]
2. The modulatory role of prime identified compounds in Geophila repens in mitigating scopolamine-induced neurotoxicity in experimental rats of Alzheimer's disease via attenuation of cholinesterase, β-secretase, MAPt levels and inhibition of oxidative stress imparts inflammation.
Dash UC; Swain SK; Kanhar S; Banjare P; Roy PP; Dandapat J; Sahoo AK
J Ethnopharmacol; 2022 Jan; 282():114637. PubMed ID: 34534598
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effects of Quercetin in Alzheimer's Disease.
Khan H; Ullah H; Aschner M; Cheang WS; Akkol EK
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905923
[TBL] [Abstract][Full Text] [Related]
4. Phytochemical profiling and in vitro screening for anticholinesterase, antioxidant, antiglucosidase and neuroprotective effect of three traditional medicinal plants for Alzheimer's Disease and Diabetes Mellitus dual therapy.
Penumala M; Zinka RB; Shaik JB; Mallepalli SKR; Vadde R; Amooru DG
BMC Complement Altern Med; 2018 Mar; 18(1):77. PubMed ID: 29499679
[TBL] [Abstract][Full Text] [Related]
5. Aqueous-ethanol extracts of some South African seaweeds inhibit beta-amyloid aggregation, cholinesterases, and beta-secretase activities in vitro.
Olasehinde TA; Olaniran AO; Okoh AI
J Food Biochem; 2019 Jul; 43(7):e12870. PubMed ID: 31353743
[TBL] [Abstract][Full Text] [Related]
6. Semisynthesis and biological evaluation of prenylated resveratrol derivatives as multi-targeted agents for Alzheimer's disease.
Puksasook T; Kimura S; Tadtong S; Jiaranaikulwanitch J; Pratuangdejkul J; Kitphati W; Suwanborirux K; Saito N; Nukoolkarn V
J Nat Med; 2017 Oct; 71(4):665-682. PubMed ID: 28600778
[TBL] [Abstract][Full Text] [Related]
7. Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
Wang J; Cai P; Yang XL; Li F; Wu JJ; Kong LY; Wang XB
Eur J Med Chem; 2017 Oct; 139():68-83. PubMed ID: 28800459
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Multi-Target Performance of Mitochondriotropic Antioxidants against the Pivotal Alzheimer's Disease Pathophysiological Hallmarks.
Benfeito S; Fernandes C; Vilar S; Remião F; Uriarte E; Borges F
Molecules; 2020 Jan; 25(2):. PubMed ID: 31936622
[TBL] [Abstract][Full Text] [Related]
9. Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease.
García-Font N; Hayour H; Belfaitah A; Pedraz J; Moraleda I; Iriepa I; Bouraiou A; Chioua M; Marco-Contelles J; Oset-Gasque MJ
Eur J Med Chem; 2016 Aug; 118():178-92. PubMed ID: 27128182
[TBL] [Abstract][Full Text] [Related]
10. New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition.
Estrada M; Pérez C; Soriano E; Laurini E; Romano M; Pricl S; Morales-García JA; Pérez-Castillo A; Rodríguez-Franco MI
Future Med Chem; 2016 Jul; 8(11):1191-207. PubMed ID: 27402296
[TBL] [Abstract][Full Text] [Related]
11. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
Maqbool M; Manral A; Jameel E; Kumar J; Saini V; Shandilya A; Tiwari M; Hoda N; Jayaram B
Bioorg Med Chem; 2016 Jun; 24(12):2777-88. PubMed ID: 27157006
[TBL] [Abstract][Full Text] [Related]
12. Design of multi-target compounds as AChE, BACE1, and amyloid-β(1-42) oligomerization inhibitors: in silico and in vitro studies.
Hernández-Rodríguez M; Correa-Basurto J; Martínez-Ramos F; Padilla-Martínez II; Benítez-Cardoza CG; Mera-Jiménez E; Rosales-Hernández MC
J Alzheimers Dis; 2014; 41(4):1073-85. PubMed ID: 24762947
[TBL] [Abstract][Full Text] [Related]
13. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
Calabrese V; Butterfield DA; Stella AM
Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
[TBL] [Abstract][Full Text] [Related]
14. Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines.
Romero A; Marco-Contelles J
Curr Top Med Chem; 2017; 17(31):3328-3335. PubMed ID: 29332586
[TBL] [Abstract][Full Text] [Related]
15. Natural antioxidants in Alzheimer's disease.
Mancuso C; Bates TE; Butterfield DA; Calafato S; Cornelius C; De Lorenzo A; Dinkova Kostova AT; Calabrese V
Expert Opin Investig Drugs; 2007 Dec; 16(12):1921-31. PubMed ID: 18042001
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
17. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
Melo JB; Sousa C; Garção P; Oliveira CR; Agostinho P
Eur J Neurosci; 2009 Feb; 29(3):455-64. PubMed ID: 19222556
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of novel indandione derivatives as multifunctional agents with cholinesterase inhibition, anti-β-amyloid aggregation, antioxidant and neuroprotection properties against Alzheimer's disease.
Mishra CB; Manral A; Kumari S; Saini V; Tiwari M
Bioorg Med Chem; 2016 Aug; 24(16):3829-41. PubMed ID: 27353888
[TBL] [Abstract][Full Text] [Related]
19. New Tacrines as Anti-Alzheimer's Disease Agents. The (Benzo)Chromeno- PyranoTacrines.
Oset-Gasque MJ; Marco-Contelles J
Curr Top Med Chem; 2017; 17(31):3349-3360. PubMed ID: 29332585
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of the marine macroalga Gelidiella acerosa: identification of active compounds through bioactivity-guided fractionation.
Syad AN; Rajamohamed BS; Shunmugaiah KP; Kasi PD
Pharm Biol; 2016 Oct; 54(10):2073-81. PubMed ID: 26933930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
